Altre lingue GSK plc

Azioni

GSK

GB00BN7SWP63

Tempo reale stimato Cboe Europe Altri mercati azionari 14:28:38 04/06/2024			Variaz. 5gg	Var. 1 gen.
1.619 ^GBX	+1,30%		-7,16%	+11,40%

13:29	GSK : UBS mantiene la raccomandazione Buy	ZD
11:46	GSK : prospettiva positiva di Deutsche Bank	ZD

Altre lingue

Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!

Registrazione 100% gratuita

GSK : obtient des résultats positifs dans le cancer du rectum	11:43
ANALYST RECOMMENDATIONS : Kinder Morgan, Marathon Petroleum, Autodesk, Cloudflare, Okta...	11:24
Jemperli (dostarlimab) trial continues to show unprecedented results with no evidence of disease in 100% of patients with locally advanced mismatch repair deficient (dMMR) rectal cancer \| GSK	10:22
Top Midday Stories: NYSE Resolves Technical Issues; Paramount, Skydance Agree to Merger Terms; Waste Management to Acquire Stericycle; GameStop Soars on 'Roaring Kitty' Stake Purchase	03/06
Point marchés-L'Europe termine en ordre dispersé, Wall Street hésite à mi-séance	03/06
GSK's Zantac Woes Weigh on FTSE 100	03/06
Etwas fester - GSK brechen wegen Zantac ein	03/06
FTSE 100 down amid shaky start in New York	03/06
Global markets live: GSK, Walt Disney, Blackstone, Boeing, Microsoft...	03/06
European Equities Traded in the US as American Depositary Receipts Fall in Monday Trading	03/06
GSK’s Rectal Cancer Drug Shows 100% Complete Response Rate in Longer-term Phase 2 Trial	03/06
Börsen bauen Gewinne aus - Atos brechen ein	03/06
Trending : GSK Shares Tumble on Zantac's Legal Setback	03/06
Sector Update: Health Care Stocks Steady Premarket Monday	03/06
GSK Says Cancer Drug Jemperli Shows 100% Clinical Response Rate in Long-Term Data From Mid-Stage Trial	03/06
GSK immunotherapy bowel cancer drug works for 100% of patients	03/06
GSK : Jemperli (dostarlimab) trial continues to show unprecedented results with no evidence of disease in 100% of patients with locally advanced mismatch repair deficient (dMMR) rectal cancer - Form 6-K	03/06
Sector Update: Health Care	03/06
Actualización de las fuertes variaciones del día: Atos, GSK, Skanska, Norwegian Air Shuttle	03/06
Pharmakonzerne müssen sich Zantac-Klagen stellen - Kursrutsch bei GSK	03/06

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Filtri

In prima pagina

GSK plc torna di nuovo in pista

03 maggio 2024 alle 13:42

GSK PLC : Inizio incoraggiante per il 2024; aumentata la guidance

01 maggio 2024 alle 17:38